Skip to main content

Rain Therapeutics raises $125M in 5th Bay Area life science IPO in 8 days

The Newark cancer therapeutics business hit the middle of its IPO price targets with the offering.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.